In adults with major depressive disorder (MDD), effective treatment has been associated with increases in both heart rate variability (HRV) and cortical thickness. However, the impact of treatment on these indices has not yet been examined in adolescents. Cortical thickness and HRV were measured in twelve adolescents with MDD before and after 8 weeks of treatment with a selective serotonin reuptake inhibitor (SSRI). We examined treatment-related changes in depression symptoms, HRV, heart rate (HR), and cortical thickness, and analyzed correlations among these change indices. At follow-up, patients showed significantly decreased depression severity, increased HRV and increased thickness of the left medial orbitofrontal cortex (OFC). Clinical improvement was associated with increased HRV and decreased HR. Increased HRV was associated with increased cortical thickness of left lateral OFC and superior frontal cortex. Due to the small sample size, results represent preliminary findings that need replication. Further, in the absence of a placebo arm, we cannot confirm that the observed effects are due solely to medication. These preliminary findings suggest that SSRI treatment in adolescents impacts both cortical thickness and autonomic functioning. Confirmation of these findings would support OFC thickness and HRV as neurobiological mediators of treatment outcome.
Introduction
The vast majority of mental health disorders have their onset during adolescence (Kessler et al., 2007) . About 75% of individuals with mental illness experience first symptoms before the age of 25 years (Kessler et al., 2007) , with depression being one of the most common mental health problems in adolescents (Merikangas et al., 2009 ). The developmental neurobiology of major depressive disorder (MDD) is complex and not yet fully understood. MDD has wide-spread effects on neural circuits that mediate emotion and orchestrate a complex array of physiological systems (i.e., autonomic nervous system (ANS), endocrine, and immune systems) (Singh and Gotlib, 2014) . Research in adolescents with MDD that integrates the assessment of these multiple intersecting systems will be critical to inform theories of MDD pathogenesis and guide both monitoring and development of treatment.
Current knowledge about the neurobiology of MDD is limited as existing models are mostly grounded on cross-sectional evidence. Longitudinal research, such as studies examining treatment-related changes of neurobiological and psychological function in MDD, are essential for advancing knowledge about adolescent MDD.
Research examining heart rate variability (HRV), an index of ANS function that reflects vagal activity, has found that adults (Kemp et al., 2010) and adolescents (Koenig et al., 2016) with MDD tend to have lower HRV than controls (Sgoifo et al., 2015) . Furthermore, several previous studies have shown that in adults with MDD, clinical improvement due to treatment is associated with increases in HRV (Balogh et al., 1993; Chambers and Allen, 2002; Glassman et al., 2007; Khaykin et al., 1998) . Decrease in depression severity in adults following non-pharmacological treatments such as acupuncture (Chambers and Allen, 2002) 
